CIK: 0001831942 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 14, 2022
Total Value ($000): $431,774 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | IVERIC BIO INC | 3,217,163 | $53,791 | 12.5% | $11.13 | — | COM | 46583P102 |
| — | MERUS N V | 1,498,890 | $47,665 | 11.0% | $27.10 | — | COM | N5749R100 |
| ACRS | ACLARIS THERAPEUTICS INC | 2,672,346 | $38,856 | 9.0% | $12.93 | +17.2% | COM | 00461U105 |
| XENE | XENON PHARMACEUTICALS INC | 1,090,126 | $34,056 | 7.9% | $21.69 | +37.8% | COM | 98420N105 |
| CYTK | CYTOKINETICS INC | 704,537 | $32,113 | 7.4% | $24.17 | +59.6% | COM NEW | 23282W605 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 805,573 | $27,551 | 6.4% | $32.91 | -3.9% | COM | 74366E102 |
| — | BELLUS HEALTH INC NEW | 3,124,613 | $25,153 | 5.8% | $8.05 | — | COM NEW | 07987C204 |
| COGT | COGENT BIOSCIENCES INC | 2,281,315 | $19,574 | 4.5% | $9.41 | -7.6% | COM | 19240Q201 |
| — | CYMABAY THERAPEUTICS INC | 5,419,896 | $18,319 | 4.2% | $4.48 | — | COM | 23257D103 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 847,683 | $16,759 | 3.9% | $16.40 | +13.6% | COM | 92790C104 |
| — | SATSUMA PHARMACEUTICALS INC | 3,711,286 | $16,701 | 3.9% | $5.89 | — | COM | 80405P107 |
| — | VISTAGEN THERAPEUTICS INC | 8,464,999 | $16,507 | 3.8% | $2.12 | — | COM NEW | 92840H202 |
| CCCC | C4 THERAPEUTICS INC | 481,094 | $15,491 | 3.6% | $29.00 | +36.4% | COM STK | 12529R107 |
| CELC | CELCUITY INC | 920,464 | $12,141 | 2.8% | $25.49 | -37.2% | COM | 15102K100 |
| — | TRICIDA INC | 1,247,043 | $11,922 | 2.8% | $9.56 | — | COM | 89610F101 |
| TNYA | TENAYA THERAPEUTICS INC | 513,930 | $9,739 | 2.3% | $21.49 | +1.4% | COM | 87990A106 |
| — | ALLAKOS INC | 815,667 | $7,985 | 1.8% | $9.79 | — | COM | 01671P100 |
| KALV | KALVISTA PHARMACEUTICALS INC | 312,553 | $4,135 | 1.0% | $24.62 | -35.3% | COM | 483497103 |
| — | KRONOS BIO INC | 298,839 | $4,061 | 0.9% | $29.87 | — | COM | 50107A104 |
| DYN | DYNE THERAPEUTICS INC | 305,125 | $3,628 | 0.8% | $19.35 | -27.4% | COM | 26818M108 |
| IVA | INVENTIVA SA | 262,658 | $3,588 | 0.8% | $14.53 | — | ADS | 46124U107 |
| GNCAQ | GENOCEA BIOSCIENCES INC | 3,079,756 | $3,573 | 0.8% | $2.51 | -40.6% | COM NEW | 372427401 |
| MREO | MEREO BIOPHARMA GROUP PLC | 1,954,970 | $3,128 | 0.7% | $3.56 | — | ADS | 589492107 |
| PMVP | PMV PHARMACEUTICALS INC | 125,000 | $2,888 | 0.7% | $39.23 | -38.4% | COM | 69353Y103 |
| — | BCLS ACQUISITION CORP | 250,000 | $2,450 | 0.6% | $11.14 | — | COM CL A | G0904B105 |